Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.